121 related articles for article (PubMed ID: 36799885)
1. Application of machine learning methods to guide patient management by predicting the risk of malignancy of Bethesda III-V thyroid nodules.
D'Andréa G; Gal J; Mandine L; Dassonville O; Vandersteen C; Guevara N; Castillo L; Poissonnet G; Culié D; Elaldi R; Sarini J; Decotte A; Renaud C; Vergez S; Schiappa R; Chamorey E; Château Y; Bozec A
Eur J Endocrinol; 2023 Mar; 188(3):. PubMed ID: 36799885
[TBL] [Abstract][Full Text] [Related]
2. ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.
Barbosa TLM; Junior COM; Graf H; Cavalvanti T; Trippia MA; da Silveira Ugino RT; de Oliveira GL; Granella VH; de Carvalho GA
BMC Endocr Disord; 2019 Oct; 19(1):112. PubMed ID: 31664992
[TBL] [Abstract][Full Text] [Related]
3. Malignancy rates for Bethesda III and IV thyroid nodules: a retrospective study of the correlation between fine-needle aspiration cytology and histopathology.
Yaprak Bayrak B; Eruyar AT
BMC Endocr Disord; 2020 Apr; 20(1):48. PubMed ID: 32293401
[TBL] [Abstract][Full Text] [Related]
4. Repeat Diagnoses of Bethesda Category III Thyroid Nodules: What To Do Next?
Yoo MR; Gweon HM; Park AY; Cho KE; Kim JA; Youk JH; Son EJ
PLoS One; 2015; 10(6):e0130138. PubMed ID: 26115096
[TBL] [Abstract][Full Text] [Related]
5. The role of thyroid sonographic malignancy risk features when the fine needle aspiration biopsy result is indeterminate.
Kotecka-Blicharz A; Krzempek M; Cortez AJ; Oczko-Wojciechowska M; Czarniecka A; Nożyńska E; Chmielik E; Jarząb B; Krajewska J
Endokrynol Pol; 2022; 73(2):316-324. PubMed ID: 35593681
[TBL] [Abstract][Full Text] [Related]
6. The gray zone of thyroid nodules: Using a nomogram to provide malignancy risk assessment and guide patient management.
Yousefi E; Sura GH; Somma J
Cancer Med; 2021 Apr; 10(8):2723-2731. PubMed ID: 33763983
[TBL] [Abstract][Full Text] [Related]
7. An innovative synthetic support for immunocytochemical assessment of cytologically indeterminate (Bethesda III) thyroid nodules.
Taccogna S; Papini E; Novizio R; D'Angelo M; Turrini L; Persichetti A; Pontecorvi A; Guglielmi R
Front Endocrinol (Lausanne); 2022; 13():1078019. PubMed ID: 36531453
[TBL] [Abstract][Full Text] [Related]
8. Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study.
Steward DL; Carty SE; Sippel RS; Yang SP; Sosa JA; Sipos JA; Figge JJ; Mandel S; Haugen BR; Burman KD; Baloch ZW; Lloyd RV; Seethala RR; Gooding WE; Chiosea SI; Gomes-Lima C; Ferris RL; Folek JM; Khawaja RA; Kundra P; Loh KS; Marshall CB; Mayson S; McCoy KL; Nga ME; Ngiam KY; Nikiforova MN; Poehls JL; Ringel MD; Yang H; Yip L; Nikiforov YE
JAMA Oncol; 2019 Feb; 5(2):204-212. PubMed ID: 30419129
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of sonographic features in indeterminate pediatric thyroid nodules.
Richman DM; Cherella CE; Smith JR; Modi BP; Zendejas B; Frates MC; Wassner AJ
Eur J Endocrinol; 2021 May; 184(5):657-665. PubMed ID: 33635830
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Lobectomy for Bethesda III Thyroid Nodules: Pathological Outcomes and Risk Factors for Malignancy.
Walters BK; Garrett SL; Aden JK; Williams GM; Butler-Garcia SL; Newberry TR; Mckinlay AJ
Ann Otol Rhinol Laryngol; 2021 Sep; 130(9):1064-1068. PubMed ID: 33567896
[TBL] [Abstract][Full Text] [Related]
11. Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses.
Rossi M; Lupo S; Rossi R; Franceschetti P; Trasforini G; Bruni S; Tagliati F; Buratto M; Lanza G; Damiani L; Degli Uberti E; Zatelli MC
Endocrine; 2017 Jul; 57(1):98-107. PubMed ID: 27623969
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of the 'CUT' Score for Assessing Malignancy in Bethesda 3 and 4 Thyroid Nodules in North American Population: A Retrospective Study.
Shihabi AN; Hussein M; Toraih EA; Attia AS; Youssef MR; Elnahla A; Omar M; Shama M; Corsetti R; Kandil E
Cancer Invest; 2022 Sep; 40(8):693-699. PubMed ID: 35549502
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound criteria (EU-TIRADS) to identify thyroid nodule malignancy risk in adolescents. Correlation with cyto-histological findings.
Yeste Fernández D; Vega Amenabar E; Coma Muñoz A; Arciniegas Vallejo L; Clemente León M; Planes-Conangla M; Iglesias Felip C; Sábado Álvarez C; Guillén Burrieza G; Campos-Martorell A
Endocrinol Diabetes Nutr (Engl Ed); 2021 Dec; 68(10):728-734. PubMed ID: 34924161
[TBL] [Abstract][Full Text] [Related]
14. Risk Stratifying Indeterminate Thyroid Nodules With Machine Learning.
Luong G; Idarraga AJ; Hsiao V; Schneider DF
J Surg Res; 2022 Feb; 270():214-220. PubMed ID: 34706298
[TBL] [Abstract][Full Text] [Related]
15. Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS).
Ho AS; Sarti EE; Jain KS; Wang H; Nixon IJ; Shaha AR; Shah JP; Kraus DH; Ghossein R; Fish SA; Wong RJ; Lin O; Morris LG
Thyroid; 2014 May; 24(5):832-9. PubMed ID: 24341462
[TBL] [Abstract][Full Text] [Related]
16. Performance of a Genomic Sequencing Classifier for the Preoperative Diagnosis of Cytologically Indeterminate Thyroid Nodules.
Patel KN; Angell TE; Babiarz J; Barth NM; Blevins T; Duh QY; Ghossein RA; Harrell RM; Huang J; Kennedy GC; Kim SY; Kloos RT; LiVolsi VA; Randolph GW; Sadow PM; Shanik MH; Sosa JA; Traweek ST; Walsh PS; Whitney D; Yeh MW; Ladenson PW
JAMA Surg; 2018 Sep; 153(9):817-824. PubMed ID: 29799911
[TBL] [Abstract][Full Text] [Related]
17. Thyroid nodules with indeterminate cytopathology: a constant challenge in everyday practice. The effectiveness of clinical decisions using diagnostic tools available in Poland.
Kotecka-Blicharz A; Pfeifer A; Czarniecka A; Oczko-Wojciechowska M; Nożyńska E; Chmielik E; Jarząb M; Jarząb B; Krajewska J
Pol Arch Intern Med; 2021 Dec; 131(12):. PubMed ID: 34633157
[TBL] [Abstract][Full Text] [Related]
18. Development of a clinical decision model for thyroid nodules.
Stojadinovic A; Peoples GE; Libutti SK; Henry LR; Eberhardt J; Howard RS; Gur D; Elster EA; Nissan A
BMC Surg; 2009 Aug; 9():12. PubMed ID: 19664278
[TBL] [Abstract][Full Text] [Related]
19. Machine Learning-Assisted Diagnostic System for Indeterminate Thyroid Nodules.
Chen L; Chen M; Li Q; Kumar V; Duan Y; Wu KA; Pierce TT; Samir AE
Ultrasound Med Biol; 2022 Aug; 48(8):1547-1554. PubMed ID: 35660106
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic utility of fine needle aspiration cytology in pediatric thyroid nodules based on Bethesda Classification.
Jiang W; Phillips SA; Newbury RO; Naheedy JH; Newfield RS
J Pediatr Endocrinol Metab; 2021 Apr; 34(4):449-455. PubMed ID: 33629571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
